BioLargo ( (BLGO) ) has released its Q2 earnings. Here is a breakdown of the information BioLargo presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
BioLargo, Inc. is a Delaware-based company specializing in innovative platform technologies aimed at addressing environmental challenges such as PFAS contamination, water treatment, and air quality control. The company operates in the environmental technology sector and is known for its focus on disruptive technologies and strategic partnerships.
In its latest earnings report for the quarter ending June 30, 2025, BioLargo reported a net loss of $1.882 million, an increase from the $780,000 loss in the same period last year. The company generated $2.777 million in revenue, a decrease from $5.014 million in the previous year, reflecting a challenging market environment.
Key financial metrics reveal that BioLargo’s product revenue fell significantly, while service revenue saw an increase. The company reported a gross profit of $1.421 million, down from $2.137 million the previous year. Operating expenses rose to $3.223 million, leading to an operating loss of $1.802 million. Despite these challenges, the company managed to secure $3.699 million in net cash from financing activities, which helped offset the cash used in operations.
Looking ahead, BioLargo’s management acknowledges the need for increased revenues and additional investment capital to sustain operations and fund new technology developments. The company remains focused on leveraging its technological assets through various business strategies, including potential partnerships and market expansion.